What is Liliana Bustamante's specialty?

Liliana Bustamante (NPI 1881987303) is a Medicare-billing provider whose primary specialty is Hematology-Oncology in Cape Coral, FL.

Where does Liliana Bustamante practice?

Liliana Bustamante practices in Cape Coral, FL, based on the location reported in the CMS Medicare provider datasets for NPI 1881987303.

How much does Medicare pay Liliana Bustamante?

Liliana Bustamante (NPI 1881987303) received approximately $7.0M in total Medicare Part B payments, serving 1,468 beneficiaries, per the CMS Medicare Physician & Other Practitioners dataset.

PROVIDER PROFILE · NPI 1881987303

Liliana BustamanteMD

PRACTICEFLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLCSee all providers at this practice →

Hematology-OncologyCape Coral, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

5,957

Unique beneficiaries

—

Total services

203,196

Distinct HCPCS

Medicare payment

$3.4M

Peer benchmark

Total Medicare services vs. 737 Hematology-Oncology providers in FL — top quintile (cohort median 1,932).

PRESCRIBING · PART D · 2024

Total Rx claims

1,967

Beneficiaries

—

Total drug cost

$6.8M

Distinct drugs

Brand share

35.5%

Top prescribed drugs

Letrozole482 claims

Lenalidomide110 claims

Hydroxyurea90 claims

Ondansetron85 claims

Zanubrutinib83 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$7K

Payment records

164

By payment type

Food and Beverage$3K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$2K

Consulting Fee$2K

Top paying entities

Food and Beverage$3K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$2K

Consulting Fee$2K

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history